Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 †
Titel:
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 †
Auteur:
Piccart, M. Hortobagyi, G.N. Campone, M. Pritchard, K.I. Lebrun, F. Ito, Y. Noguchi, S. Perez, A. Rugo, H.S. Deleu, I. Burris III, H.A. Provencher, L. Neven, P. Gnant, M. Shtivelband, M. Wu, C. Fan, J. Feng, W. Taran, T. Baselga, J.